BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection

Transplantation

Volumn 88, Issue 10, 2009, Pages 1229-1230

  Zarkhin, Valeriya ^a   Li, Li ^a   Sarwal, Minnie M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B CELL ACTIVATING FACTOR; CHEMOKINE RECEPTOR CXCR5; CREATININE; CXCL13 CHEMOKINE; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; RITUXIMAB; STROMAL CELL DERIVED FACTOR 1; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; B LYMPHOCYTE; CELL SURVIVAL; CREATININE CLEARANCE; DRUG EFFICACY; HOMEOSTASIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; LETTER; LYMPHOCYTE DEPLETION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL SURVIVAL; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION;

EID: 73849145030     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bbba1a     Document Type: Letter

References (9)

1. Zarkhin V, Li L, Kambham N, et al. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation. Am J Transplant 2008; 8: 2607.
2. Zarkhin V, Kambham N, Li L, et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008; 74: 664.
3. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125.
4. Zarkhin V, Li L, Sarwal M. "To B or not to B?" B-cells and graft rejection. Transplantation 2008; 85: 1705.
5. Stadanlick JE, Cancro MP. BAFF and the plasticity of peripheral B cell tolerance. Curr Opin Immunol 2008; 20: 158.
6. Pers JO, Daridon C, Bendaoud B, et al. B-cell depletion and repopulation in autoimmune diseases. Clin Rev Allergy Immunol 2008; 34: 50.
7. Xu H, He X, Sun J, et al. The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allo-graft rejection. Transplant Proc 2009; 41: 112.
8. Badr G, Borhis G, Lefevre EA, et al. BAFF enhances chemotaxis of primary human B cells: A particular synergy between BAFF and CXCL13on memoryBcells. Blood 2008; 111: 2744.
9. Thaunat O, Patey N, Gautreau C, et al. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation 2008; 85: 1648.